Future Science Group

In this interview, Joop Arends discusses his thoughts on the future of diagnosis and management of hepatitis C, and also gives us his highlights from ECCMID.

In this interview, Greg Roman (Waters Corporation, USA) shares his experience with instrumentation and techniques such as LC–MS and HRMS and explains what drew him to the field.

In this edition of NCTalks, Lauren Pulling speaks to Emery Brown, Professor of Anesthesia at Harvard Medical School (MA, USA). Dr Brown has delivered a number of lectures in recent years on deciphering the dynamics of the brain under general anaesthesia, and how the potential of this area may currently be under-utilized. In this podcast we’ll hear more about Dr Brown’s work, how general anesthesia...

In this EpigenomicsNet podcast, Professor Hendrik Stunnenberg (Radboud University, Nijmegen, Netherlands) discusses his work in gene expression, investigating regulatory epigenetic mechanisms and provides a summary of his talk on the epigenome of innate immune cells.

In this EpigenomicsNet podcast, Dr En Li (Novartis Institutes for BioMedical Research, Shanghai, China) discusses his work leading Novartis’ research program in Shanghai and provides a summary of his talk on Novartis’ epigenetic research in cancer.

In this EpigenomicsNet podcast, Dr Danette Daniels (Promega, Madison, WI, USA) discusses her work at Promega in the area of functional proteomics and provides a summary of her talk introducing Promega’s technologies to study and characterize protein interactions inside cells, particularly for chromatin analysis.

In this MedChemNet podcast, Professor Paul Fish (University College London, UK) discusses his work in Alzheimer’s drug discovery and the talk he delivered on the discovery of fit for purpose chemical probes to investigate bromodomain proteins and the three new drug discovery institutes funded by Alzheimer’s research UK.

In this MedChemNet podcast, Professor Michelle Arkin (University of California, San Francisco; San Francisco, CA, USA) discusses her work in academic drug discovery and chemical biology and the talk she delivered on the progression of inhibiting protein-protein interactions and utilizing this to potentially re-modulate disease networks to a healthy state.

In this MedChemNet podcast, Dr Gemma Nixon (University of Liverpool, UK) discusses her work in antimalarial, antituberculosis, anti-filariasis and antifungal drug discovery and development and the talk she delivered on the development of the antimalarial E209.

In this podcast Dr Elizabeth Whittaker, Dr James Seddon, Dr Pete Dodd and Professor Beate Kampmann discuss their work in pediatric tuberculosis focusing on the areas of immunology, modelling and drug resistance.

In this edition of NCTalks, we speak to Robyn Klein, a Professor of Medicine, Immunobiology and Neuroscience at Washington University School of Medicine in St Louis, Missouri in the USA. Robyn’s research focuses on the pathogenesis of neuroinflammatory diseases in the CNS, specifically the mechanism of leukocyte recruitment into the CNS, and the direct effects of inflammatory mediators on resident...

Two key themes to come out of the Alzheimer’s Research UK (ARUK) Conference (Aberdeen, UK, 14–15 March 2017) were the celebration of world-class research, and hope for the future of dementia understanding, prevention and treatment, particularly with the forging and strengthening of new partnerships, collaborations and initiatives. In May 2016, ARUK committed £50 million to support the MRC-led UK D...

In part 2 of The Changing World of Bioanalysis our panelists discuss what the bioanalytical lab of the future might look like. Discussions included: The need for bioanalysts to acquire more biological skills in order to understand newer generation of complex molecules. Convergence of different units of companies and merging of skills. The role of automation in the bioanalytical lab of the future.

In part 1 of this 3-part video filmed at Barcelona our panel of experts discuss the issue of skills gap in the bioanalytical laboratory and the changing nature of the relationship between Pharma and CROs as outsourcing continues to increase. Discussions include: - Decreasing current skills gap evident in most bioanalytical labs, particularly in younger generation of bioanalysts. - Collaborations b...

In this RegMedNet podcast, Mike Rice explains the make or break impact of biopreservation in the potential commercialization of cell therapies.

Our RegMedNet Podcast talks to Dr Aric Rogers about how he is studying factors such as genetic variations and environmental conditions that can influence life span using roundworms. Dr Rogers provides his thoughts and predictions on how dietary restriction for therapeutic benefits could be adopted for the future.

Our RegmedNet Podcast talks to Dr Sandra Rieger about how the Rieger lab uses zebrafish as a model to study wound healing mechanisms and nerve regeneration in peripheral neuropathy. Dr Sandra Rieger provides her thoughts and opinions on the future of zebrafish in research, and future regenerative medicine therapies.

In this NCTalks podcast, we’re reporting from Neuroscience 2016 in San Diego (CA, USA; 12–16 November 2016). We spoke to Patricia Garcez from the Federal University of Rio Janeiro in Brazil, who presented at the conference her work on Zika virus and its disruption of normal cell division and differentiation. Zika virus was highlighted as one of the key research themes at the conference and remains...

In this NCTalks podcast we speak to Jeffrey Cohen, Director of the Cleveland Clinic’s Mellen Center for Multiple Sclerosis Treatment and Research (OH, USA). Dr Cohen has a large clinical practice and is also Director of Experimental Therapeutics program and is involved in a number of clinical trials. Today, Dr Cohen discusses the use of bone marrow transplantation as a treatment option for relapsi...

In this edition of NCTalks we speak to Mark Frasier, Senior Vice President of research programs at the Michael J. Fox Foundation for Parkinson’s Research (NY, USA). Mark co-manages a team of research professionals who are developing a targeted and innovative agenda for accelerating research and drug development for Parkinson’s disease. Mark also supports the Foundation’s priority interest in devel...

As part of attending Neuroscience 2016 #SFN, our team took the time to interview Erica McGrath, 5th year graduate student at the University of Texas Medical Branch. Erica McGrath's work is focused on the Zika infection and the effect it has on neurological development.

In this edition of NCTalks for ADHD Awareness Month, we speak to Edward Hallowell, a child and adult psychiatrist, leading ADHD authority, New York Times bestselling author, world-renowned speaker and the founder of The Hallowell Centers for Cognitive and Emotional Health, located across the USA. Dr Hallowell is a graduate of Harvard College (MA, USA) and Tulane University School of Medicine (LA,...

In this NCTalks podcast, we speak to Dr Reid Alisch, Assistant Professor in the Department of Psychiatry at the University of Wisconsin School of Medicine (WI, USA). Reid discusses the role of epigenetics in neuropsychiatric and neurodegenerative disorders, as well as how new epigenetic research could change research and treatment practices in the future.

The goal of the field of regenerative medicine is to replace damaged or diseased tissue and thereby find cures for diseases that are currently untreatable. At present, two different approaches appear feasible: one is to stimulate the body's own cells to repair the tissue; and the other is to transplant new cells into the body, but both approaches are classed cell therapies. The drive to move regen...

3D bioprinting looks set to have a huge impact on the field of regenerative medicine by allowing the artificial generation of tissues and organs through fabrication of scaffolds and 3D tissues, supporting cell or drug delivery, and so on. However, this requires the development and use of biomaterials that meet the physical, chemical and functional requirements for each use. In this interview, Dann...